PulseAI
Healthcare Software · United Kingdom · 1-10 Employees
View Company Info for Free
Overview
Headquarters
United KingdomWebsite
www.pulseai.ioRevenue
<$5 MillionIndustry
About PulseAI
Is PulseAI your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if PulseAI had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at PulseAI
Funding: Get notified immidiatlly once PulseAI has new funding data
Check if PulseAI has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on PulseAI recently announced quarterly report
Check out if PulseAI is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when PulseAI launches new products
PulseAI, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
PulseAI is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
PulseAI is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about PulseAI.
PulseAI Tech Stack
A closer look at the technologies used by PulseAI
PulseAI News & Media
PulseAI Secures Seed Funding to Advance AI-Driven ECG Diagnostics
BELFAST, Northern Ireland , Jan. 12, 2026 /PRNewswire/ -- PulseAI, a rapidly emerging leader in AI-enabled cardiac diagnostics, today announced the closing of its seed funding round, led by Innovation Ulster Limited, with participation from The Mortara Group and The Francis Crick...Trinity Biotech Announces Strategic Collaboration with Medical Artificial Intelligence Company PulseAI
DUBLIN, Ireland, May 16, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) a commercial stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced a strategic collaboration with medical artificial intelligence (“AI”) company PulseAI to enhance the Company’s recently acquired continuous glucose monitor (CGM) biosensor technology.PulseAI's Groundbreaking AI Algorithm Enhances Consumer ECG Diagnostics
Innovative AI Application Improves Cardiac Monitoring and Diagnostic Accuracy BELFAST, Northern Ireland , Jan. 11, 2024 /PRNewswire/ -- PulseAI, a leader in artificial intelligence healthcare solutions, today announced a significant advancement in consumer device electrocardiogram (ECG)...Study Shows PulseAI's Deep Learning Algorithm Outperforms the Apple Watch ECG Algorithm in Detecting Atrial Fibrillation
BELFAST, Northern Ireland, May 19, 2023 /PRNewswire/ -- PulseAI, a leader in the development of cutting-edge AI-powered ECG software, has released the results of a clinical study that has shown the superiority of its deep learning AI over the Apple Watch ECG algorithm in the detection of...
Top Healthcare Software Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding PulseAI
PulseAI specializes in AI-powered ECG diagnostics, offering accurate, accessible, and scalable cardiac diagnostic solutions. Their technology focuses on early detection of heart disease through deep learning algorithms. The company provides various services including API integration, on-device algorithms, and consultancy. PulseAI aims to partner wi... Read More